Dihexa is a synthetic peptide derived from angiotensin IV, classified as a neuroactive compound with potential cognitive-enhancing properties. Researchers primarily study it for its effects on neuroplasticity and memory consolidation, particularly in the context of neurodegenerative diseases such as Alzheimer's disease. Key findings from preclinical studies indicate that dihexa can penetrate the blood-brain barrier and promote synaptogenesis, enhancing cognitive performance in models of cognitive impairment. Additionally, studies suggest that it activates the hepatocyte growth factor/c-Met receptor system, which is implicated in neurogenesis and neuronal protection. Current research continues to explore its therapeutic potential and mechanisms of action, although clinical trials are still needed to establish its efficacy in human populations.